Recent ethical debates in longevity science highlight public support for life extension with equity, expert calls for transparency, and policy integration to address ageism and access disparities. Adv...
Analytical exploration of how geroscience, epigenetic reprogramming, and AI-driven therapies are converging to extend healthspan, with insights on clinical trials, societal impacts, and future trends....
Biotech advancements in thymus regeneration, like TECregen’s therapies, show promise in rejuvenating immune function for aging populations, addressing delivery challenges and ethical considerati...
Recent studies reveal GDF3’s role in driving inflammation in aging fat tissue, with new therapies targeting the SMAD2/3 axis showing promise for improving metabolic health and extending healthsp...
